Preventive cardiology is a significant aspect of cardiovascular medicine, emphasizing risk factor management to reduce the likelihood of cardiovascular diseases. Lifestyle modifications, including a heart-healthy diet, regular exercise, smoking cessation, and blood pressure control, form the foundation of preventive strategies. Cardiovascular medicine also involves the management of chronic conditions, such as hypertension and diabetes, to prevent complications and optimize heart health. The field recognizes the importance of a multidisciplinary approach, with collaboration between cardiologists, primary care physicians, nurses, dietitians, and other healthcare professionals. Advances in cardiovascular medicine extend beyond clinical care to include research into novel therapies, genetics, and personalized medicine, aiming to address the diverse and evolving nature of cardiovascular diseases. Ultimately, cardiovascular medicine plays a pivotal role in improving patient outcomes, enhancing quality of life, and contributing to the ongoing global effort to reduce the burden of cardiovascular diseases.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India